Allmed Solutions Ltd (TA:ALMD) — Market Cap & Net Worth
Market Cap & Net Worth: Allmed Solutions Ltd (ALMD)
Allmed Solutions Ltd (TA:ALMD) has a market capitalization of $7.99 Million (ILA2.98 Billion) as of September 17, 2026. Listed on the TA stock exchange, this Israel-based company holds position #27700 globally and #392 in its home market, demonstrating a 5.08% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Allmed Solutions Ltd's stock price ILA31.00 by its total outstanding shares 96099551 (96.10 Million). Also see Allmed Solutions Ltd total assets for a full breakdown of the balance sheet.
Allmed Solutions Ltd Market Cap History: 2015 to 2026
Allmed Solutions Ltd's market capitalization history from 2015 to 2026. Data shows change from $34.52 Million to $7.99 Million (-15.16% CAGR). Also see Allmed Solutions Ltd cash flow conversion for how efficiently the company converts equity into cash flow.
Allmed Solutions Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Allmed Solutions Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check ALMD stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
2.05x
Allmed Solutions Ltd's market cap is 2.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.06x
Allmed Solutions Ltd's market cap is 4.06 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $29.89 Million | $7.35 Million | -$23.92 Million | 4.06x | N/A |
| 2017 | $31.07 Million | $7.70 Million | -$22.68 Million | 4.03x | N/A |
| 2018 | $14.32 Million | $9.28 Million | -$20.18 Million | 1.54x | N/A |
| 2019 | $12.75 Million | $11.15 Million | $21.99 Million | 1.14x | 0.58x |
| 2020 | $13.81 Million | $9.72 Million | -$8.66 Million | 1.42x | N/A |
| 2021 | $11.39 Million | $5.54 Million | $2.81 Million | 2.05x | 4.06x |
Competitor Companies of ALMD by Market Capitalization
Companies near Allmed Solutions Ltd in the global market cap rankings as of September 17, 2026. Review Allmed Solutions Ltd tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Allmed Solutions Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.42 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #232 globally with a market cap of $107.98 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.42 Billion | $102.03 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.75 |
| #232 | Stryker Corporation | NYSE:SYK | $107.98 Billion | $281.50 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Allmed Solutions Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Allmed Solutions Ltd's market cap moved from $34.52 Million to $ 7.99 Million, with a yearly change of -15.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA7.99 Million | -10.66% |
| 2025 | ILA8.94 Million | +2.97% |
| 2024 | ILA8.68 Million | -8.92% |
| 2023 | ILA9.53 Million | +49.80% |
| 2022 | ILA6.36 Million | -44.12% |
| 2021 | ILA11.39 Million | -17.54% |
| 2020 | ILA13.81 Million | +8.28% |
| 2019 | ILA12.75 Million | -10.97% |
| 2018 | ILA14.32 Million | -53.90% |
| 2017 | ILA31.07 Million | +3.97% |
| 2016 | ILA29.89 Million | -13.43% |
| 2015 | ILA34.52 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Allmed Solutions Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.99 Million USD |
| MoneyControl | $7.99 Million USD |
| MarketWatch | $7.99 Million USD |
| marketcap.company | $7.99 Million USD |
| Reuters | $7.99 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Allmed Solutions Ltd
Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers drugs, biological products, and medical devices; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires. It… Read more